Search Results - "Gunthard, H. F."

On the potential of a short‐term intensive intervention to interrupt HCV transmission in HIV‐positive men who have sex with men: A mathematical modelling study by Salazar‐Vizcaya, L., Kouyos, R. D., Fehr, J., Braun, D., Estill, J., Bernasconi, E., Delaloye, J., Stöckle, M., Schmid, P., Rougemont, M., Wandeler, G., Günthard, H. F., Keiser, O., Rauch, A.

“…Summary Increasing access to direct‐acting antiviral (DAA) treatment for hepatitis C virus (HCV) infection and decelerating the rise in high‐risk behaviour…”
Get full text

Genetic Composition of Human Immunodeficiency Virus Type 1 in Cerebrospinal Fluid and Blood without Treatment and during Failing Antiretroviral Therapy by STRAIN, M. C, LETENDRE, S, MARQUIE-BECK, J, DURELLE, J, GRANT, I, RICHMAN, D. D, MARCOTTE, T, MCCUTCHAN, J. A, ELLIS, R. J, WONG, J. K, PILLAI, S. K, RUSSELL, T, IGNACIO, C. C, GÜNTHARD, H. F, GOOD, B, SMITH, D. M, WOLINSKY, S. M, FURTADO, M

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

A LC–tandem MS assay for the simultaneous measurement of new antiretroviral agents: Raltegravir, maraviroc, darunavir, and etravirine by Fayet, A., Béguin, A., Zanolari, B., Cruchon, S., Guignard, N., Telenti, A., Cavassini, M., Günthard, H.F., Buclin, T., Biollaz, J., Rochat, B., Decosterd, L.A.

“…Raltegravir (RAL), maraviroc (MVC), darunavir (DRV), and etravirine (ETV) are new antiretroviral agents with significant potential for drug interactions. This…”
Get full text

Heterogeneous Clearance Rates of Long-Lived Lymphocytes Infected with HIV: Intrinsic Stability Predicts Lifelong Persistence by Strain, M. C., Günthard, H. F., Havlir, D. V., Ignacio, C. C., Smith, D. M., Leigh-Brown, A. J., Macaranas, T. R., Lam, R. Y., Daly, O. A., Fischer, M., Opravil, M., Levine, H., Bacheler, L., Spina, C. A., Richman, D. D., Wong, J. K.

“…Viral replication and latently infected cellular reservoirs persist in HIV-infected patients achieving undetectable plasma virus levels with potent…”
Get full text

Efavirenz Intoxication Due to Slow Hepatic Metabolism by Hasse, B., Günthard, H. F., Bleiber, G., Krause, M.

“…We describe a human immunodeficiency virus–positive woman who presented with severe psychosis while she was receiving therapy with efavirenz. Her plasma…”
Get full text

Antiretroviral Resistance during Successful Therapy of HIV Type 1 Infection by Martinez-Picado, J., DePasquale, M. P., Kartsonis, N., Hanna, G. J., Wong, J., Finzi, D., Rosenberg, E., Gunthard, H. F., Sutton, L., Savara, A., Petropoulos, C. J., Hellmann, N., Walker, B. D., Richman, D. D., Siliciano, R., D'Aquila, R. T.

“…HIV type 1 (HIV-1) drug resistance mutations were selected during antiretroviral therapy successfully suppressing plasma HIV-1 RNA to <50 copies/ml. New…”
Get full text

Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral‐naïve persons starting treatment by Mocroft, A, Neesgard, B, Zangerle, R, Rieger, A, Castagna, A, Spagnuolo, V, Antinori, A, Lampe, FC, Youle, M, Vehreschild, JJ, Mussini, C, Borghi, V, Begovac, J, Duvivier, C, Gunthard, HF, Rauch, A, Tiraboschi, J, Chkhartishvili, N, Bolokadze, N, Wit, F, Wasmuth, JC, De Wit, S, Necsoi, C, Pradier, C, Svedhem, V, Stephan, C, Petoumenos, K, Garges, H, Rogatto, F, Peters, L, Ryom, L

“…Objectives Although outcomes of antiretroviral therapy (ART) have been evaluated in randomized controlled trials, experiences from subpopulations defined by…”
Get full text

Mining for pairs: shared clinic visit dates identify steady HIV‐positive partnerships by Marzel, A, Shilaih, M, Turk, T, Campbell, NK, Yang, W‐L, Böni, J, Yerly, S, Klimkait, T, Aubert, V, Furrer, H, Calmy, A, Battegay, M, Cavassini, M, Bernasconi, E, Schmid, P, Metzner, KJ, Günthard, HF, Kouyos, RD, Bucher, H. C., Burton‐Jeangros, C., Dollenmaier, G., Egger, M., Elzi, L., Fehr, J., Fellay, J., Fux, C. A., Gorgievski, M., Haerry, D., Hasse, B., Hirsch, H. H., Hoffmann, M., Hösli, I., Kahlert, C., Kaiser, L., Keiser, O., Kovari, H., Ledergerber, B., Martinetti, G., Tejada, B. Martinez, Müller, N., Nadal, D., Nicca, D., Pantaleo, G., Rauch, A., Regenass, S., Rickenbach, M., Rudin, C., Schöni‐Affolter, F., Schmid, P., Schüpbach, J., Speck, R., Tarr, P., Trkola, A., Vernazza, P., Weber, R., Yerly, S.

“…Objectives Here we examined the hypothesis that some stable HIV‐infected partnerships can be found in cohort studies, as the patients frequently attend the…”
Get full text

Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia by Wong, Joseph K., Hezareh, Marjan, Gunthard, Huldrych F., Havlir, Diane V., Ignacio, Caroline C., Spina, Celsa A., Richman, Douglas D.

“…In evaluating current combination drug regimens for treatment of human immunodeficiency virus (HIV) disease, it is important to determine the existence of…”
Get full text

Chemsex drugs on the rise: a longitudinal analysis of the Swiss HIV Cohort Study from 2007 to 2017 by Hampel, B, Kusejko, K, Kouyos, RD, Böni, J, Flepp, M, Stöckle, M, Conen, A, Béguelin, C, Künzler‐Heule, P, Nicca, D, Schmidt, AJ, Nguyen, H, Delaloye, J, Rougemont, M, Bernasconi, E, Rauch, A, Günthard, HF, Braun, DL, Fehr, J, Anagnostopoulos, A., Battegay, M., Bucher, H. C., Calmy, A., Cavassini, M., Ciuffi, A., Dollenmaier, G., Egger, M., Elzi, L., Fellay, J., Furrer, H., Fux, C. A., Haerry, D., Hasse, B., Hirsch, H. H., Hoffmann, M., Hösli, I., Huber, M., Kahlert, C., Kaiser, L., Keiser, O., Klimkait, T., Kovari, H., Ledergerber, B., Martinetti, G., Martinez de Tejada, B., Marzolini, C., Metzner, K. J., Müller, N., Paioni, P., Pantaleo, G., Perreau, M., Rudin, C., Scherrer, A. U., Schmid, P., Speck, R., Tarr, P., Trkola, A., Vernazza, P., Wandeler, G., Weber, R., Yerly, S.

“…Objectives Chemsex refers to the use of sex‐enhancing drugs among men who have sex with men (MSM) in combination with specific sexual and social behaviours…”
Get full text

Successful Treatment with Miltefosine of Disseminated Cutaneous Leishmaniasis in a Severely Immunocompromised Patient Infected with HIV-1 by Schraner, Christine, Hasse, Barbara, Hasse, Urs, Baumann, Doris, Faeh, Anja, Burg, Günther, Grimm, Felix, Mathis, Alex, Weber, Rainer, Günthard, Huldrych F.

“…We describe here a case of disseminated cutaneous leishmaniasis due to Leishmania major in a severely immunocompromised patient from Burkino Faso, Africa, who…”
Get full text

Predictive Value of Known and Novel Alleles of CYP2B6 for Efavirenz Plasma Concentrations in HIV‐infected Individuals by Rotger, M, Tegude, H, Colombo, S, Cavassini, M, Furrer, H, Décosterd, L, Blievernicht, J, Saussele, T, Günthard, H F, Schwab, M, Eichelbaum, M, Telenti, A, Zanger, U M

“…To assess the association of CYP2B6 allelic diversity with efavirenz (EFV) pharmacokinetics, we performed extensive genotyping of 15 relevant single nucleotide…”
Get full text

Efficacy of etravirine combined with darunavir or other ritonavir‐boosted protease inhibitors in HIV‐1‐infected patients: an observational study using pooled European cohort data by Vingerhoets, J, Calvez, V, Flandre, P, Marcelin, A‐G, Ceccherini‐Silberstein, F, Perno, C‐F, Mercedes Santoro, M, Bateson, R, Nelson, M, Cozzi‐Lepri, A, Grarup, J, Lundgren, J, Incardona, F, Kaiser, R, Sonnerborg, A, Clotet, B, Paredes, R, Günthard, HF, Ledergerber, B, Hoogstoel, A, Nijs, S, Tambuyzer, L, Lavreys, L, Opsomer, M

“…Objectives This observational study in antiretroviral treatment‐experienced, HIV‐1‐infected adults explored the efficacy of etravirine plus darunavir/ritonavir…”
Get full text

Effect of Influenza Vaccination on Viral Replication and Immune Response in Persons Infected with Human Immunodeficiency Virus Receiving Potent Antiretroviral Therapy by Günthard, Huldrych F., Wong, Joseph K., Spina, Celsa A., Ignacio, Caroline, Kwok, Shirley, Christopherson, Cindy, Hwang, Jimmy, Haubrich, Richard, Havlir, Diane, Richman, Douglas D.

“…Nineteen patients infected with human immunodeficiency virus (HIV) with varying levels of viral suppression achieved with antiretroviral therapy were evaluated…”
Get full text

Gonococcal tonsillar infection: A case report and literature review by BALMELLI, C, GÜNTHARD, H. F

“…Oral gonococcal infection is an uncommon but well-described manifestation of gonococcal infection, usually described as pharyngitis in the literature…”
Get full text

Rapid Progression of Kidney Dysfunction in People Living With HIV: Use of Polygenic and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Risk Scores by Dietrich, Léna G, Thorball, Christian W, Ryom, Lene, Burkhalter, Felix, Hasse, Barbara, Thurnheer, Maria Christine, Weisser, Maja, Schmid, Patrick, Bernasconi, Enos, Darling, Kathrine E A, Buvelot, Hélène, Fellay, Jacques, Ledergerber, Bruno, Tarr, Philip E

“…In people with human immunodeficiency virus (PWH), it is unknown whether genetic background associates with rapid progression of kidney dysfunction (ie,…”
Get full text

Liver failure after long-term nucleoside antiretroviral therapy by Kronenberg, A, Riehle, HM, Günthard, HF

Get full text

Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study by Álvarez, Hortensia, Mocroft, Amanda, Ryom, Lene, Neesgaard, Bastian, Edwards, Simon, Svedhem, Veronica, Günthard, Huldrych F, Zangerle, Robert, Smith, Colette, Castagna, Antonella, d’Arminio Monforte, Antonella, Wit, Ferdinand, Stecher, Melanie, Lehman, Clara, Mussini, Cristina, Fontas, Eric, González, Eva, Wasmuth, Jan-Christian, Sönnerborg, Anders, De Wit, Stéphane, Chkhartishvili, Nikoloz, Stephan, Christoph, Petoumenos, Kathy, Jaschinski, Nadine, Vannappagari, Vani, Gallant, Joel, Young, Lital, Volny Anne, Alain, Greenberg, Lauren, Martín-Iguacel, Raquel, Poveda, Eva, Llibre, Josep M

“…Abstract Background There are conflicting data regarding baseline determinants of virological nonsuppression outcomes in persons with human immunodeficiency…”
Get full text

Comparative performance of high-density oligonucleotide sequencing and dideoxynucleotide sequencing of HIV type 1 pol from clinical samples by Günthard, H F, Wong, J K, Ignacio, C C, Havlir, D V, Richman, D D

“…The performance of the high-density oligonucleotide array methodology (GeneChip) in detecting drug resistance mutations in HIV-1 pol was compared with that of…”
Get more information

Aortic homograft endocarditis caused by Rhodotorula mucilaginosa by MAEDER, M, VOGT, P. R, SCHAER, G, VON GRAEVENITZ, A, GÜNTHARD, H. F

“…Serious infections caused by Rhodotorula spp. are rare and usually occur in immunocompromised people, especially in patients with tumors and long-time use of…”
Get full text